Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Clin Dermatol
Autors principals: Blauvelt, Andrew, Papp, Kim A., Griffiths, Christopher E. M., Puig, Luis, Weisman, Jamie, Dutronc, Yves, Kerr, Lisa Farmer, Ilo, Dapo, Mallbris, Lotus, Augustin, Matthias
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2018
Matèries:
Correction
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5945710/
https://ncbi.nlm.nih.gov/pubmed/29600394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-018-0353-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars